PTAB Invalidates Humira Patent In Coherus Challenge
The Patent Trial and Appeal Board invalidated a key patent for AbbVie Biotechnology Ltd.'s mega-blockbuster autoimmune disease drug Humira on Tuesday, finding the patent would have been obvious at the time...To view the full article, register now.
Already a subscriber? Click here to view full article